TUG1 targeting enhances anticancer immunity thereby facilitating lenvatinib efficacy in hepatocellular carcinoma - Genes & Immunity Genes & Immunity - TUG1 targeting enhances anticancer immunity thereby facilitating lenvatinib efficacy in hepatocellular carcinoma

#TUG1 targeting enhances #anticancer #immunity thereby facilitating #lenvatinib efficacy in #hepatocellular #carcinoma

#Genes & #Immunity @springernature.com
www.nature.com/articles/s41...